title: [A new opportunity in ovarian cancer treatment].
abstract: OBJECTIVE
  Targeted treatment in ovarian cancer patients.
  
  
  METHODS
  Practical paper.
  
  
  METHODS
  Department of Gynecology and Obstetrics, Medical Faculty Charles University, Prague and University Hospital, Hradec Králové.
  
  
  CONCLUSIONS
  Targeted treatment is possible based on particular characteristics of single tumors in ovarian cancer patients. Better understanding of tumor biology should contribute to predict certain patients would benefit most from use of targeted treatment.
authors.affiliation: porodnická a Gynekologická klinica LF UK a FN, Hradec Králové, prednosta doc. MUDr. J. Tosner, CSc. Sedlakova@seznam.cz
authors.forename: I
authors.initials: I
authors.lastname: Sedláková
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D000068258:Bevacizumab; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000188:drug therapy*
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab